Platelet activation markers in patients with peripheral arterial disease. A prospective comparison of different platelet function tests

Thrombosis and Haemostasis

Volumn 78, Issue 6, 1997, Pages 1434-1437

  Gresele, Paolo ^a   Catalano, Mariella ^b   Giammarresi, Carlo ^c   Volpato, Raul ^a   Termini, Rosanna ^c   Ciabattoni, Giovanni ^d   Nenci, Giuseppe G ^a   Davì, Giovanni ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

11 OXOTHROMBOXANE B2; BETA THROMBOGLOBULIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING PARAMETERS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; URINARY EXCRETION;

EID: 0030681317     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1665429     Document Type: Article

References (23)

1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
2. Ross R. The pathogenesis of atherosclerosis. In: Heart Disease. Braunwald E, ed. Philadelphia: Saunders 1988; 1135-52.
3. Ward AS, Porter N, Preston FE, Morris Jones W. Platelet aggregation in patients with peripheral vascular disease. Atherosclerosis 1978; 29: 63-8.
4. Cella G, Zahavi J, de Haas HA, Kakkar VV. Betathromboglobulin, platelet production time and platelet function in vascular disease. Br J Haematol 1979; 43: 127-36.
5. Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202.
6. The Pack Trial Group. Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, doubleblind, placebo controlled trial. Thromb Res 1989; 55: 13-23.
7. Knapp HR, Healy C, Lawson J, FitzGerald GA. Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. Thromb Res 1988; 50: 377-86.
8. O' Brien JR, Etherington MD. Platelet α-granule proteins in stroke and transient ischemic attacks. Lancet 1984; 1: 231-2.
9. 2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients. Thromb Res 1990; 57: 437-44.
10. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 117-26.
11. 2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. Thromb Res 1982: 26: 359-70.
12. Gresele P, Arnout J, Deckmyn H, Huybrechts E, Pieters G, Vermylen J. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. J Clin Invest 1987; 80: 1435-45.
13. Gresele P, Dottorini M, Selli ML, Iannacci L, Canino S, Todisco T, Romano S, Crook P, Page CP, Nenci GG. Altered platelet function associated with the bronchial hyperesponsiveness accompanying nocturnal asthma. J All Clin Immunol 1993; 91: 894-902.
14. Davì G, Catalane I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990; 322: 1769-74.
15. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
16. D'Souza D, Wu KK, Hellums JD, Phillips MD. Platelet activation and arterial thrombosis. Lancet 1994; 344: 991-5.
17. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med 1996; 239: 17-34.
18. Patrono C, Davi G, Ciabattoni G. Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Trends Cardiovasc Med 1992; 2: 15-20.
19. Reilly IAG, Doran JB, Smith B, FitzGerald GA. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation 1986; 73: 1300-9.
20. Vejar M, Fragasso G, Hackett D, Lipkin DP, Maseri A, Born GVR, Ciabattoni G, Patrono C. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 1990; 63: 163-8.
21. FitzGerald GA, Smith B, Pedersen AK, Brash AR. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 1984; 310: 1065-8.
22. Sinzinger H, Virgolini I, Fitscha P. Platelet kinetics in patients with atherosclerosis. Thromb Res 1990; 57: 507-16.
23. Nenci GG, Gresele P, Agnelli G, Parise P. Intrinsically defective or exhausted platelets in hairy cell leukemia? Thromb Haemost 1981; 46: 572.